Moneycontrol
Get App
Last Updated : Apr 08, 2019 12:15 PM IST | Source: PTI

Caplin Point Laboratories subsidiary inks pact with Baxter Healthcare for generic injectable portfolio

As a part of the deal, Caplin Steriles, a wholly owned subsidiary of Caplin Point Laboratories Ltd, will out-license five of its injectable Abbreviated New Drug Applications to Baxter Healthcare Corporation.

Representative image
Representative image

Drug firm Caplin Point Laboratories on April 8 said its subsidiary has entered into a license and supply agreement with Baxter Healthcare Corporation for five generic injectable portfolio.

As a part of the deal, Caplin Steriles, a wholly owned subsidiary of Caplin Point Laboratories Ltd, will out-license five of its injectable Abbreviated New Drug Applications (ANDAs) to Baxter Healthcare Corporation.

"Caplin Steriles Ltd has entered into a license and supply agreement with Baxter Healthcare Corporation for five generic injectable ANDAs," Caplin Point Laboratories said in a regulatory filing.

Close

Specific terms of the agreement and financial details, however, were not disclosed.

"All these ANDAs have been developed in-house, and we are keen to license them to Baxter, who have an excellent sales and marketing infrastructure in the US for commercialisation of these products," Caplin Point Laboratories Chairman C C Paarthipan said.

Shares of Caplin Point Laboratories were trading 2.36 percent higher at Rs 396.45 apiece on BSE.

Subscribe to Moneycontrol Pro and gain access to curated markets data, exclusive trading recommendations, independent equity analysis, actionable investment ideas, nuanced takes on macro, corporate and policy actions, practical insights from market gurus and much more.
First Published on Apr 8, 2019 12:02 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant